Thomas C. Hohman
Neurotech (United States)(US)
Publications by Year
Research Areas
Aldose Reductase and Taurine, Retinal Diseases and Treatments, Prenatal Substance Exposure Effects, Pain Mechanisms and Treatments, Cannabis and Cannabinoid Research
Most-Cited Works
- → Novel spirosuccinimides with incorporated isoindolone and benzisothiazole 1,1-dioxide moieties as aldose reductase inhibitors and antihyperglycemic agents(1992)187 cited
- → Hypertonic stress induces αB-crystallin expression(1992)185 cited
- → Reticular Drusen Associated with Geographic Atrophy in Age-Related Macular Degeneration(2011)177 cited
- → Molecular mechanisms of glucose action on angiotensinogen gene expression in rat proximal tubular cells(1999)117 cited
- → Optical Coherence Tomography and Autofluorescence Findings in Areas with Geographic Atrophy Due to Age-Related Macular Degeneration(2010)102 cited
- → Effect of High Glucose on Mesangial Cell Protein Kinase C-δ and -ε is Polyol Pathway-Dependent(1999)81 cited
- → Aldose reductase and polyol in cultured pericytes of human retinal capillaries(1989)75 cited
- → Double-Masked, Randomized, Phase 2 Evaluation of Abicipar Pegol (an Anti-VEGF DARPin Therapeutic) in Neovascular Age-Related Macular Degeneration(2018)74 cited
- → Functional Characterization of Abicipar-Pegol, an Anti-VEGF DARPin Therapeutic That Potently Inhibits Angiogenesis and Vascular Permeability(2018)72 cited
- → Effect of hyperglycemia and the aldose reductase inhibitor tolrestat on sural nerve biochemistry and morphometry in advanced diabetic peripheral polyneuropathy(1993)68 cited